421 related articles for article (PubMed ID: 2536788)
1. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
2. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
Weigle KA; Grose C
J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
Arvin AM; Koropchak CM
J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
[TBL] [Abstract][Full Text] [Related]
5. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
[TBL] [Abstract][Full Text] [Related]
6. Frequency and specificity of varicella zoster virus IgM response.
Sundqvist VA
J Virol Methods; 1982 Nov; 5(3-4):219-27. PubMed ID: 6296180
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Wittek AE; Arvin AM; Koropchak CM
J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
Takayama M
Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell.
Friedrichs WE; Grose C
J Virol; 1986 Jan; 57(1):155-64. PubMed ID: 3001341
[TBL] [Abstract][Full Text] [Related]
10. Antibody class capture assays for varicella-zoster virus.
Forghani B; Myoraku CK; Dupuis KW; Schmidt NJ
J Clin Microbiol; 1984 May; 19(5):606-9. PubMed ID: 6330163
[TBL] [Abstract][Full Text] [Related]
11. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
Brunell PA; Novelli VM; Keller PM; Ellis RW
J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.
Hacham M; Leventon-Kriss S; Sarov I
Intervirology; 1980; 13(4):214-22. PubMed ID: 6248482
[TBL] [Abstract][Full Text] [Related]
14. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
15. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
Schmidt NJ; Gallo D
J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
[TBL] [Abstract][Full Text] [Related]
16. Serological responses in varicella and zoster assayed by immunoblotting.
Harper DR; Kangro HO; Heath RB
J Med Virol; 1988 Aug; 25(4):387-98. PubMed ID: 2844983
[TBL] [Abstract][Full Text] [Related]
17. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
18. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibody to varicella-zoster virus by competitive and IgM-antibody capture immunoassay.
Tedder RS; Mortimer PP; Lord RB
J Med Virol; 1981; 8(2):89-101. PubMed ID: 6271923
[TBL] [Abstract][Full Text] [Related]
20. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
J Infect Dis; 1986 May; 153(5):840-7. PubMed ID: 3009635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
